Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather L Cox

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Infection Control and Hospital Epidemiology|November 24, 2018
Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile TestingGregory R Madden, Heather L Cox, Melinda D Poulter, et al.
Antimicrobial Agents and Chemotherapy|February 17, 2021
Consecutive antibiotic shortages highlight discrepancies between microbiology and prescribing practices for intra-abdominal infectionsStacy C Park, Grace R Gillis-Crouch, Heather L Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus BacteremiaJoshua C Eby, Morgan M Richey, James A Platts-Mills, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2017
Reply to Weinbren and CollinsJoshua C Eby, Amy J Mathers, Heather L Cox, et al.
Journal of Clinical Microbiology|November 24, 2012
First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new worldAmy J Mathers, Kevin C Hazen, Joanne Carroll, et al.
Integrative and Comparative Biology|April 4, 2009
Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public healthCatherine J Walsh, Carl A Luer, A B Bodine, et al.
Infection Control and Hospital Epidemiology|April 13, 2018
Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial IncentiveGregory R Madden, Ian German Mesner, Heather L Cox, et al.
Mbio|November 3, 2011
Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmidAmy J Mathers, Heather L Cox, Brandon Kitchel, et al.
Journal of Clinical Microbiology|July 26, 2019
The Role of <i>fosA</i> in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical IsolatesZachary S Elliott, Katie E Barry, Heather L Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?Evan D Robinson, Allison M Stilwell, April E Attai, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Infection Control and Hospital Epidemiology|November 24, 2018
Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile TestingGregory R Madden, Heather L Cox, Melinda D Poulter, et al.
Antimicrobial Agents and Chemotherapy|February 17, 2021
Consecutive antibiotic shortages highlight discrepancies between microbiology and prescribing practices for intra-abdominal infectionsStacy C Park, Grace R Gillis-Crouch, Heather L Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus BacteremiaJoshua C Eby, Morgan M Richey, James A Platts-Mills, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2017
Reply to Weinbren and CollinsJoshua C Eby, Amy J Mathers, Heather L Cox, et al.
Journal of Clinical Microbiology|November 24, 2012
First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new worldAmy J Mathers, Kevin C Hazen, Joanne Carroll, et al.
Integrative and Comparative Biology|April 4, 2009
Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public healthCatherine J Walsh, Carl A Luer, A B Bodine, et al.
Infection Control and Hospital Epidemiology|April 13, 2018
Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial IncentiveGregory R Madden, Ian German Mesner, Heather L Cox, et al.
Mbio|November 3, 2011
Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmidAmy J Mathers, Heather L Cox, Brandon Kitchel, et al.
Journal of Clinical Microbiology|July 26, 2019
The Role of <i>fosA</i> in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical IsolatesZachary S Elliott, Katie E Barry, Heather L Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?Evan D Robinson, Allison M Stilwell, April E Attai, et al.
Pageof 3